$42.60+45.64% · 3M
Moving avg
1W+8.45%
1M+10.08%
3M+45.64%
6M+64.23%
YTD+64.42%
1Y+180.08%
3Y+100.47%
5Y+423.34%
52-week range
$14.32100% of range$41.23
Company health
Value0/6
Growth0/6
Profitability0/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Net cash on the balance sheet
Risks
- Burning free cash flow
Key statistics
Valuation
Market cap
$8.79B
Enterprise value
$7.11B
P/E ratio (TTM)
-14.04x
P/S ratio (TTM)
0.00x
EV/EBITDA
-14.08x
Per share & returns
EPS (TTM)
-$2.48
Dividend yield
0.00%
Beta (1Y)
0.77
30-day change
+10.08%
Trading
Volume (24h)
1.96M
Previous close
$40.93
Shares outstanding
206.40M
About Immunovant, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
IMVT
Immunovant, Inc. is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker IMVT.
Frequently asked questions
What is Immunovant, Inc.'s market cap?
Immunovant, Inc. (IMVT) has a market capitalization of $8.79B.
What sector is Immunovant, Inc. in?
Immunovant, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does IMVT trade on?
IMVT trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 363.90-0.44%
$355.89B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.48-0.58%
$288.36B cap
AstraZeneca PLCLON: AZN
£116.44-0.50%
$243.42B cap